Assessment of the Efficacy of Rosuvastatin in Patient Groups With a Dissimilar Risk Profile in an Observational Study (HEROS)

CompletedOBSERVATIONAL
Timeline

Start Date

May 31, 2003

Study Completion Date

April 30, 2005

Conditions
HypercholesterolemiaCoronary Heart DiseasePeripheral Vascular DiseaseCerebrovascular AccidentDiabetes
Interventions
DRUG

Rosuvastatin

Oral

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY